BNP PARIBAS ASSET MANAGEMENT Holding S.A. Sells 361,764 Shares of CVS Health Co. (NYSE:CVS)

BNP PARIBAS ASSET MANAGEMENT Holding S.A. trimmed its position in shares of CVS Health Co. (NYSE:CVS - Free Report) by 62.5% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 217,353 shares of the pharmacy operator's stock after selling 361,764 shares during the quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A.'s holdings in CVS Health were worth $13,667,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. MidAtlantic Capital Management Inc. acquired a new stake in shares of CVS Health in the third quarter valued at approximately $25,000. Livelsberger Financial Advisory purchased a new position in shares of CVS Health during the third quarter valued at approximately $31,000. Reston Wealth Management LLC purchased a new position in CVS Health during the third quarter worth approximately $32,000. Kathleen S. Wright Associates Inc. purchased a new position in CVS Health during the third quarter worth approximately $33,000. Finally, First Community Trust NA increased its position in shares of CVS Health by 116.2% in the second quarter. First Community Trust NA now owns 562 shares of the pharmacy operator's stock worth $33,000 after acquiring an additional 302 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on CVS shares. Royal Bank of Canada lowered their price target on shares of CVS Health from $68.00 to $58.00 and set an "outperform" rating for the company in a report on Friday, November 15th. Truist Financial restated a "buy" rating and issued a $67.00 price target (down from $76.00) on shares of CVS Health in a research report on Wednesday. Wells Fargo & Company upgraded shares of CVS Health from an "equal weight" rating to an "overweight" rating and lifted their price objective for the company from $60.00 to $66.00 in a research report on Monday, November 18th. Evercore ISI boosted their price target on shares of CVS Health from $62.00 to $75.00 and gave the stock an "outperform" rating in a research report on Tuesday, October 8th. Finally, Barclays lowered their price objective on shares of CVS Health from $75.00 to $71.00 and set an "overweight" rating on the stock in a research note on Thursday, November 7th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and thirteen have issued a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $72.28.

CVS Health Stock Performance

Shares of CVS Health stock traded up $0.91 during trading on Friday, reaching $58.01. The company's stock had a trading volume of 11,153,900 shares, compared to its average volume of 12,620,673. The business's 50-day moving average price is $59.21 and its 200-day moving average price is $58.63. The firm has a market cap of $73.00 billion, a PE ratio of 14.72, a P/E/G ratio of 0.96 and a beta of 0.55. CVS Health Co. has a 52 week low of $52.71 and a 52 week high of $83.25. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, beating analysts' consensus estimates of $1.08 by $0.01. The business had revenue of $95.43 billion during the quarter, compared to the consensus estimate of $92.72 billion. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. CVS Health's revenue for the quarter was up 6.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.21 earnings per share. Equities analysts forecast that CVS Health Co. will post 5.43 earnings per share for the current year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, November 1st. Investors of record on Monday, October 21st were issued a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.59%. The ex-dividend date of this dividend was Monday, October 21st. CVS Health's dividend payout ratio is currently 67.51%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.